v3.26.3
Commitments and contingencies - Censa agreement (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 25, 2026
USD ($)
D
Aug. 05, 2025
USD ($)
Sep. 30, 2026
USD ($)
Jun. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Jul. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
May 05, 2020
USD ($)
Commitments and contingencies                      
Revenue     $ 357,807   $ 211,007 $ 990,877 $ 1,565,978        
Milestone Payable     80,000   32,500 80,000 32,500 $ 416      
Sangamo asset acquisition                      
Commitments and contingencies                      
Milestone event notification period | D 15                    
Maximum milestone payment due period | D 20                    
Sangamo asset acquisition | Upon Accelerated FDA Approval                      
Commitments and contingencies                      
Non-refundable payment $ 80,000                    
Sangamo asset acquisition | Upon Full FDA Approval                      
Commitments and contingencies                      
Non-refundable payment 20,000                    
Product                      
Commitments and contingencies                      
Revenue     275,894   $ 130,956 740,286 $ 402,711        
Censa Merger Agreement                      
Commitments and contingencies                      
Maximum amount of upfront consideration     500,000 $ 250,000   500,000          
Rights Satisfaction Agreement                      
Commitments and contingencies                      
Maximum amount of upfront consideration   $ 250,000                  
Maximum amount of additional milestone payable   100,000                  
Additional milestone payable for right holders   500,000                  
Payment of upfront consideration   225,100                  
Additional milestone obligated to be paid   $ 90,000                  
Rights Satisfaction Agreement | Annual net sales less than or equal to $250 million                      
Commitments and contingencies                      
Percentage on annual net sales   8.00%                  
Rights Satisfaction Agreement | Annual net sales greater than $250 million but less than $500 million                      
Commitments and contingencies                      
Percentage on annual net sales   10.00%                  
Rights Satisfaction Agreement | Annual net sales greater than $500 million                      
Commitments and contingencies                      
Percentage on annual net sales   12.00%                  
Rights Satisfaction Agreement | First occurrence of a three or fewer consecutive calendar year period                      
Commitments and contingencies                      
Threshold consecutive calendar period   3 years                  
Amount of net sales of product   $ 3,000,000                  
Rights Satisfaction Agreement | First occurrence of a five or fewer consecutive calendar year period                      
Commitments and contingencies                      
Threshold consecutive calendar period   5 years                  
Amount of net sales of product   $ 5,000,000                  
Rights Satisfaction Agreement | First occurrence of a seven or fewer consecutive calendar year period                      
Commitments and contingencies                      
Threshold consecutive calendar period   7 years                  
Amount of net sales of product   $ 7,000,000                  
Rights Satisfaction Agreement | First occurrence of a nine or fewer consecutive calendar year period                      
Commitments and contingencies                      
Threshold consecutive calendar period   9 years                  
Amount of net sales of product   $ 9,000,000                  
Rights Satisfaction Agreement | First occurrence of a eleven or fewer consecutive calendar year period                      
Commitments and contingencies                      
Threshold consecutive calendar period   11 years                  
Amount of net sales of product   $ 11,000,000                  
Minimum | Rights Satisfaction Agreement | Product | Annual net sales greater than $250 million but less than $500 million                      
Commitments and contingencies                      
Revenue   250,000                  
Minimum | Rights Satisfaction Agreement | Product | Annual net sales greater than $500 million                      
Commitments and contingencies                      
Revenue   500,000                  
Maximum | Sangamo asset acquisition | Upon Full FDA Approval                      
Commitments and contingencies                      
Non-refundable payment $ 100,000                    
Maximum | Rights Satisfaction Agreement | Product | Annual net sales less than or equal to $250 million                      
Commitments and contingencies                      
Revenue   250,000                  
Maximum | Rights Satisfaction Agreement | Product | Annual net sales greater than $250 million but less than $500 million                      
Commitments and contingencies                      
Revenue   $ 500,000                  
Censa                      
Commitments and contingencies                      
Asset acquisition, development and regulatory milestones                     $ 109,000
Censa | Censa Merger Agreement                      
Commitments and contingencies                      
Milestone payments triggered     50,000 30,000   50,000       $ 25,000  
Milestone Payable                 $ 32,500    
Threshold revenue to milestone payment     $ 500,000 $ 250,000              
Censa | Maximum                      
Commitments and contingencies                      
Asset acquisition, milestone, amount                     217,500
Asset acquisition, net sales milestone                     $ 160,000
Former Censa Securityholders | Development and Regulatory Milestones                      
Commitments and contingencies                      
Milestone obligation payments made           152,500          
Potential milestone payments due           217,500          
Former Censa Securityholders | Rights Satisfaction Agreement                      
Commitments and contingencies                      
Ownership percentage prior to merger   90.00%                  
Sephience | Censa                      
Commitments and contingencies                      
Royalty payments           4,100          
Tegsedi | Censa                      
Commitments and contingencies                      
Royalty payments           4,300          
Waylivra | Censa                      
Commitments and contingencies                      
Royalty payments           $ 3,400